Correlation Between UBS AG and ResMed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both UBS AG and ResMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UBS AG and ResMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UBS AG London and ResMed Inc, you can compare the effects of market volatilities on UBS AG and ResMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UBS AG with a short position of ResMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of UBS AG and ResMed.

Diversification Opportunities for UBS AG and ResMed

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between UBS and ResMed is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding UBS AG London and ResMed Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ResMed Inc and UBS AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UBS AG London are associated (or correlated) with ResMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ResMed Inc has no effect on the direction of UBS AG i.e., UBS AG and ResMed go up and down completely randomly.

Pair Corralation between UBS AG and ResMed

Given the investment horizon of 90 days UBS AG London is expected to generate 0.34 times more return on investment than ResMed. However, UBS AG London is 2.93 times less risky than ResMed. It trades about 0.16 of its potential returns per unit of risk. ResMed Inc is currently generating about -0.02 per unit of risk. If you would invest  1,853  in UBS AG London on January 25, 2024 and sell it today you would earn a total of  526.00  from holding UBS AG London or generate 28.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

UBS AG London  vs.  ResMed Inc

 Performance 
       Timeline  
UBS AG London 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in UBS AG London are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, UBS AG may actually be approaching a critical reversion point that can send shares even higher in May 2024.
ResMed Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ResMed Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, ResMed is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

UBS AG and ResMed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with UBS AG and ResMed

The main advantage of trading using opposite UBS AG and ResMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UBS AG position performs unexpectedly, ResMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ResMed will offset losses from the drop in ResMed's long position.
The idea behind UBS AG London and ResMed Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stocks Directory
Find actively traded stocks across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios